e.krastev
TL2 · Ilorin
Contributes reviews on supplier material. Based in Ilorin.
Joined 17 June 2025 · last posted 9d · groups: regional-apac
80 posts, newest first. Showing up to 150.
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #81 · Nutrition & Training › Protein & intake · 19 Jul 2026 · 0 likes Density matters more than quantity when total intake is limited. The same protein in a smaller volume is the whole game. I have deliberately not rounded that, because…
-
About the Adverse events category Replied, post #6 · Safety › Adverse events · 15 Jul 2026 · 0 likes Psychological adverse events: mood changes, anxiety, or suicidal ideation warrant discussion with a mental health professional. These are rare but real.
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #84 · Evidence › Journal club · 6 Jul 2026 · 30 likes I would keep SURMOUNT-OSA and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is…
-
Why the timeline is on the right and not the left — what changed since Replied, post #67 · Meta › Site feedback · 4 Jul 2026 · 10 likes Something worth flagging about timeline: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
-
Historical amylin analogues and what happened to them Replied, post #24 · Compounds › Cagrilintide & amylin analogues · 27 Jun 2026 · 7 likes Coming back to post #20, because the follow-up matters more than the original answer. Comparing an amylin analogue to an incretin agonist on weight change alone misses…
-
Second pass at: Programming during a large energy deficit Replied, post #46 · Nutrition & Training › Resistance training · 26 Jun 2026 · 0 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #19 · Analytics › Impurities & related substances · 23 Jun 2026 · 14 likes Deletion sequences arise from incomplete coupling and are lower by one residue mass. Where they elute depends on the hydrophobicity of the residue that is missing, so…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #69 · Meta › Announcements · 22 Jun 2026 · 0 likes Building on post #68 rather than restating it. The documentation on Trust level 3 requirements is better than this thread and I say that as someone who has posted in…
-
GLP-1 receptor distribution: central and peripheral Replied, post #73 · Pharmacology › Receptor biology · 20 Jun 2026 · 6 likes GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on neurons (appetite and gastric motility), and on myocardium…
-
What to include when your question involves a chromatogram — one year on Replied, post #39 · Start Here › How to Ask · 16 Jun 2026 · 2 likes "Has anyone had this happen" gets you anecdotes. "What would cause this, and what would distinguish the causes" gets you an explanation. The second question is almost…
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #14 · Sourcing › Vendor reports · 14 Jun 2026 · 20 likes Post #12 is right about the mechanism and I think understates the practical bit. Since Reconciling a supplier certificate keeps coming up, it should probably be a…
-
Submitting a sample: the process end to end Replied, post #15 · Sourcing › Independent verification · 13 Jun 2026 · 19 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible.
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #60 · Pharmacology › Pharmacokinetics · 3 Jun 2026 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #37 · Analytics › Home & field testing · 2 Jun 2026 · 0 likes The question underneath Lateral-flow and colorimetric approaches is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it.…
-
Introducing myself and asking whether my planned first topic belongs anywhere — does… Replied, post #2 · marked as the solution · Start Here › Welcome · 24 May 2026 · 23 likes You do not need to introduce yourself before asking a question, and nobody will think worse of you for arriving with one. The introductions subcategory exists for…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #19 · Compounds › Repair & healing peptides · 1 May 2026 · 32 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Request: show the solution author in the topic list — what changed since Replied, post #6 · Meta › Feature requests · 30 Apr 2026 · 3 likes Seconded. It reads as careful rather than confident, which is the right register.
-
What I would want from a home test that does not exist yet — what changed since Replied, post #7 · Analytics › Home & field testing · 30 Apr 2026 · 8 likes Picking up post #5: that is the part I would want checked first. Where home testing is genuinely valuable is as a screen before spending on independent analysis, not as…
-
Bioimpedance and hydration: why the number moves Replied, post #35 · Outcomes › Body composition · 24 Apr 2026 · 2 likes Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for detecting month-to-month changes. Useful for trend over…
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #3 · Compounds › Semaglutide · 18 Apr 2026 · 26 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
CJC-1295 with and without DAC: what the modification does Replied, post #14 · Compounds › Secretagogues & GH axis · 16 Mar 2026 · 6 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Guidelines revision: what changed and why — one year on Replied, post #79 · Meta › Announcements · 7 Mar 2026 · 0 likes Post #77 and I disagree about the size of the effect, not about the direction. Worth saying publicly: stepping back cleanly and handing over is a service. Documents…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #128 · Practice › Dosing & titration · 21 Feb 2026 · 0 likes Everything in post #124 holds. The case it does not cover is the one I have. Micro-titration: the concept of increments smaller than the labelled steps. It has no…
-
Trifluoroacetate content and its consequences Replied, post #92 · Analytics › Impurities & related substances · 6 Feb 2026 · 0 likes I read post #90 twice before replying, because I had assumed the opposite. Freeze-drying itself does not generate impurities in any significant way. Handling before and…
-
Managing an unplanned gap in supply Replied, post #23 · Access › Shortages · 5 Feb 2026 · 0 likes Post #19 put the caveat in the right place and I want to underline it. Where a shortage forces a gap, the pharmacokinetics mean a missed week is a perturbation rather…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #45 · Analytics › Method validation · 1 Feb 2026 · 0 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Journal club: LEADER as the historical anchor Replied, post #28 · Evidence › Journal club · 28 Jan 2026 · 10 likes Adding the measurement that post #25 says would settle it. The thing about LEADER that took me longest to accept is that a plausible mechanism is not evidence of an…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #53 · Clinical › Bloodwork · 16 Jan 2026 · 10 likes One more thing on panel that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
-
Reading an interaction checker output critically Replied, post #68 · Practice › Interactions · 17 Dec 2025 · 4 likes Post #66 put the caveat in the right place and I want to underline it. Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body…
-
Airline travel with a temperature-sensitive injectable Replied, post #17 · Devices › Cold chain · 24 Nov 2025 · 6 likes Where I part company with post #13, and it is a narrow parting. Airline travel would be much easier to settle if anyone reported the denominator. Almost nobody reports…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #35 · Start Here › How to Ask · 23 Nov 2025 · 0 likes Nobody minds being asked to explain a term. The people who use them most are the quickest to define them, and a question that stops to ask is usually a question that…
-
Tracking that stops updating and then resumes Replied, post #45 · Sourcing › Logistics · 12 Nov 2025 · 0 likes Post #42 answers the question as asked. The question underneath it is different. Tracking accuracy at each hop is a reasonable proxy for how much attention the shipment…
-
How to read a phase 2 result without treating it as a phase 3 result Started this topic · Compounds › Retatrutide · 4 Nov 2025 · 44 likes The question in the title: How to read a phase 2 result without treating it as a phase 3 result I will give what I have already checked below so nobody repeats it.…
-
New subcategory: rationale and scope Replied, post #31 · Meta › Announcements · 15 Oct 2025 · 24 likes I had written a reply contradicting post #30 and deleted it. Here is what survived. What I can speak to on new subcategory is narrow, so I will keep it narrow rather…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #18 · Start Here › Welcome · 13 Oct 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Sleep quality changes during weight loss — what changed since Replied, post #19 · Wellbeing › Sleep · 7 Oct 2025 · 18 likes Adding the measurement that post #18 says would settle it. Stimulants and sleep: if supplementing with caffeine or other stimulants for energy during weight loss,…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #18 · Sourcing › Vendor reports · 23 Sep 2025 · 11 likes Worth separating two things that post #15 runs together. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water,…
-
Payment method and the leverage it gives you, ranked Replied, post #51 · Sourcing › Payments · 21 Sep 2025 · 30 likes Something worth flagging about payment method: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a…
-
Pages past their review date, listed Replied, post #27 · Meta › Wiki maintenance · 5 Sep 2025 · 21 likes Nobody has said the unglamorous part of pages past yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
Confounding by indication, explained with a concrete example Replied, post #17 · Evidence › Study critique · 2 Sep 2025 · 0 likes Worth separating two things that post #15 runs together. Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you…
-
About the Mental health category Replied, post #3 · Wellbeing › Mental health · 27 Aug 2025 · 0 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #66 · Compounds › Retatrutide · 27 Aug 2025 · 13 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #32 · Practice › Storage & stability · 21 Aug 2025 · 6 likes A supplier stability statement tied to a named storage condition can be evaluated. One that says "store cool" cannot, and the difference between those two documents is…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #77 · Evidence › Journal club · 21 Aug 2025 · 28 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. I would…
-
Cross-border purchase within the EU: the actual rules Replied, post #7 · Access › International · 29 Jul 2025 · 3 likes On post #5 — agreed on the reasoning, with one qualification. Compounding in different countries: some countries allow pharmacy compounding under defined conditions;…
-
Gauge and length selection for subcutaneous injection Replied, post #13 · Devices › Syringes & needles · 19 Jul 2025 · 11 likes The thing about gauge and length selection that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a…
-
[2026 update] Mood changes: monitoring, and when to involve a professional Replied, post #14 · Wellbeing › Mental health · 11 Jul 2025 · 0 likes Mood changes reported during substantial weight loss have several plausible contributors and the drug is only one of them. Energy restriction alone is a well-documented…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #40 · Sourcing › Regulatory · 3 Jul 2025 · 3 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
Sodium, potassium and magnesium when intake drops Replied, post #30 · Nutrition & Training › Hydration & electrolytes · 25 Jun 2025 · 4 likes Where I part company with post #26, and it is a narrow parting. Small methodological point on sodium: repeating a measurement is cheap and resolves most of what is…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #57 · Devices › Pens & autoinjectors · 4 Jun 2025 · 3 likes Post #56 is the version of this I will quote in future. One addition. The instruction leaflet for a licensed pen is a genuinely good technical document and is almost…
-
Pre-registering a personal experiment, seriously Replied, post #107 · Research Methods › N-of-1 designs · 3 Jun 2025 · 0 likes Confounding in personal experiments: other things change when you start a medication (season, exercise, diet, stress). Documenting those confounders helps you…
-
Pre-registering a personal experiment, seriously Replied, post #88 · Research Methods › N-of-1 designs · 2 Jun 2025 · 0 likes The arithmetic in post #85 is right; the assumption feeding it is the part to check. Marking my uncertainty on pre-registering a personal experiment explicitly. I am…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #5 · Start Here › How to Ask · 21 May 2025 · 0 likes Adding the measurement that post #2 says would settle it. Tag your own topic. Two accurate tags do more for how findable it is than a long title, and you can change…
-
Asking about a compound your prescriber has not heard of Replied, post #35 · Clinical › Prescriber conversations · 9 May 2025 · 0 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #29 · Evidence › Journal club · 9 May 2025 · 0 likes Adding the measurement that post #26 says would settle it. The baseline characteristics table is the single most useful page for the questions that get asked here,…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #130 · Evidence › Journal club · 23 Apr 2025 · 24 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Excipient function in a licensed injectable Replied, post #3 · Pharmacology › Formulation chemistry · 18 Apr 2025 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. The honest summary: a licensed formulation is a designed system and a…
-
A well-designed study with a badly written abstract Replied, post #29 · Evidence › Study critique · 17 Apr 2025 · 28 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #76 · Compounds › Semaglutide · 14 Apr 2025 · 1 like Nothing to add on the substance. Thank you for taking the question at face value.
-
Checking someone else's arithmetic: a worked example thread Replied, post #38 · Practice › Reconstitution · 14 Apr 2025 · 1 like Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. Written…
-
Reading a trial's population section before its results — does this still hold? Replied, post #2 · Evidence › Trials · 10 Apr 2025 · 17 likes The first question about any trial is what it set out to estimate, not what it found. Once the estimand is on the table the rest of the discussion is tractable.
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #27 · Practice › Reconstitution · 24 Mar 2025 · 5 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Second pass at: Regression to the mean in progress reports Replied, post #72 · Research Methods › Statistics · 1 Mar 2025 · 26 likes Where I part company with post #71, and it is a narrow parting. A p-value is the probability of data at least this extreme given the null hypothesis. It is not the…
-
Protein density versus volume when you cannot eat much Replied, post #53 · Nutrition & Training › Protein & intake · 1 Feb 2025 · 1 like I read post #51 twice before replying, because I had assumed the opposite. My understanding of protein density versus volume is a few years old and may have been…
-
What changed in 2026, by region Replied, post #111 · Access › International · 31 Jan 2025 · 11 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks. This…
-
Coming back to: When to suspect the method rather than the sample Replied, post #112 · Analytics › Method validation · 22 Dec 2024 · 14 likes A method transferred between laboratories needs a demonstration that it performs equivalently, not just a document describing it. Transfer is where a great many…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #16 · Safety › Adverse events · 19 Dec 2024 · 27 likes Severe, persistent abdominal pain, particularly radiating to the back, is not an ordinary gastrointestinal symptom and belongs with a clinician rather than a thread.
-
Body image changing more slowly than the body Replied, post #59 · Wellbeing › Mental health · 17 Dec 2024 · 10 likes Nothing here is medical advice and several members in this subcategory say plainly that they are describing their own experience only. Where I would look next, rather…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #5 · Pharmacology › Receptor biology · 14 Dec 2024 · 1 like Glucagon receptor agonism raises energy expenditure and promotes hepatic fat oxidation. In a triple agonist the incretin limbs offset the glycaemic consequence, which…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #69 · Access › Insurance & coverage · 14 Dec 2024 · 1 like Post #65 describes the usual case. This is about the unusual one. The practical version of Step therapy requirements is three sentences long. The rigorous version is…
-
Coming back to: When to suspect the method rather than the sample Replied, post #40 · Analytics › Method validation · 7 Dec 2024 · 0 likes On post #38 — agreed on the reasoning, with one qualification. An independent laboratory's method being different from the supplier's is not a discrepancy. It becomes…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #21 · Practice › Side effects · 23 Nov 2024 · 7 likes No disagreement from me. Posting only so the question does not look ignored.
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #39 · Compounds › Semaglutide · 23 Nov 2024 · 2 likes Cardiovascular data in people without diabetes is the specific contribution of SELECT, and it is worth being precise that the enrolled population had established…
-
EMA product information as a primary source — does this still hold? Replied, post #59 · Regional › European Union · 16 Nov 2024 · 0 likes Right, and stated more narrowly than I would have dared to state it.
-
Food noise reducing and the disorientation that can follow Replied, post #24 · Wellbeing › Mental health · 18 Oct 2024 · 0 likes Where I part company with post #20, and it is a narrow parting. If you are in crisis, contact a local emergency or crisis service rather than posting. A volunteer forum…
-
A page that has drifted out of date and needs a maintainer Replied, post #16 · Documentation › Wiki requests · 7 Oct 2024 · 2 likes Narrowing post #14, because the general version has more than one answer. Format suggestions: if you think a maintained page could be clearer in its presentation…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #61 · Analytics › COA interpretation · 21 Sep 2024 · 23 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Correlation in a self-tracked dataset: what it can support Replied, post #105 · Research Methods › Statistics · 24 Aug 2024 · 25 likes Post #102 is the version of this I will quote in future. One addition. Whatever the answer on correlation turns out to be, the method for getting there is the same:…
-
Blind submission and why it changes minds Replied, post #40 · Sourcing › Independent verification · 19 Aug 2024 · 25 likes I would put moderate confidence on the mainstream reading of blind submission and no more. That is not scepticism for its own sake; it is where the sourcing actually…
-
Journal club: FLOW and the renal composite, component by component Replied, post #38 · Evidence › Journal club · 12 Jul 2024 · 4 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.